Structural analogues of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors

被引:5
|
作者
Homan, EJ
Kroodsma, E
Copinga, S
Unelius, L
Mohell, N
Wikström, HV
Grol, CJ
机构
[1] Univ Groningen, Ctr Pharm, Dept Med Chem, NL-9713 AW Groningen, Netherlands
[2] Astra Arcus AB, CNS Preclin R&D, S-15185 Sodertalje, Sweden
关键词
dopamine; serotonin; 2-aminotetralin; structure-affinity relationships;
D O I
10.1016/S0968-0896(99)00039-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several structural analogues of 5-methoxy-2-[N-(2-benzamidoethyl)-N-n-propylamino]tetralin (5-OMe-BPAT, 1), a representative of a series of 2-aminotetralin-derived benzamides with po ten tial atypical antipsychotic properties, were synthesized and evaluated for their ability to bind to dopamine D-2A, D-3, and serotonin 5-HT1A receptors in vitro. The structure-affinity relationships revealed that the aromatic ring of the benzamide moiety of 1 contributes to the high affinities for all three receptor subtypes. Furthermore, 1 may interact with the dopamine D-2 and D-3 receptors through hydrogen bond formation with its carbonyl group. Investigation of the role of the amide hydrogen atom by amide N-alkylation was not conclusive, since conformational aspects may be responsible for the decreased dopaminergic affinities of the N'-alkylated analogues of 1. The effects of the amide modifications on the serotonin 5-HT1A receptor affinity were less pronounced, suggesting that the benzamidoethyl side-chain of 1 as a whole enhances the affinity for this receptor subtype probably through hydrophobic interactions with an accessory binding site. The structural requirements for the substituents at the basic nitrogen atom supported the hypothesis that the 2-aminotetralin moieties of the 2-aminotetralin-derived substituted benzamides may share the same binding sites as the 2-(N, N-di-n-propylamino)tetralins. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1111 / 1121
页数:11
相关论文
共 50 条
  • [21] Functional characterization of the novel antipsychotic iloperidone at human D2, D3, α2C, 5-HT6, and 5-HT1A receptors
    Kalkman, HO
    Fetterbach, D
    Lötscher, E
    Schoeffter, P
    LIFE SCIENCES, 2003, 73 (09) : 1151 - 1159
  • [22] The antipsychotic aripiprazole induces antinociceptive effects: Possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors
    Almeida-Santos, Ana F.
    Ferreira, Renata C. M.
    Duarte, Igor D.
    Aguiar, Daniele C.
    Romero, Thiago R. L.
    Moreira, Fabricio A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 300 - 306
  • [23] Anxiolytic Properties of 1-Aryl-4-(phthalimidoalkyl)piperazines and Their Affinity to 5-HT1A Serotonin and D2 Dopamine Receptors
    S. A. Andronati
    S. G. Soboleva
    S. Yu. Makan
    V. M. Sava
    G. E. Kolodeev
    T. A. Voronina
    G. M. Molodavkin
    Pharmaceutical Chemistry Journal, 2003, 37 (1) : 15 - 18
  • [24] 1-cinnamyl-4-(2-methoxyphenyl)piperazines:: Synthesis, binding properties, and docking to dopamine (D2) and serotonin (5-HT1A) receptors
    Penjisevic, Jelena
    Sukalovic, Vladimir
    Andric, Deana
    Kostic-Rajacic, Sladjana
    Soskic, Vukic
    Roglic, Goran
    ARCHIV DER PHARMAZIE, 2007, 340 (09) : 456 - 465
  • [25] A broad spectrum antiemetic activity of a novel dopamine D2, D3 and serotonin 5-HT3 receptors antagonist AS-8112
    Yoshikawa, T
    Yoshida, N
    Hosoki, K
    Karasawa, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R515 - R515
  • [26] Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors: Design, Synthesis, and Effects on Behavior
    Butini, Stefania
    Gemma, Sandra
    Campiani, Giuseppe
    Franceschini, Silvia
    Trotta, Francesco
    Borriello, Marianna
    Ceres, Nicoletta
    Ros, Sindu
    Coccone, Salvatore Sanna
    Bernetti, Matteo
    De Angelis, Meri
    Brindisi, Margherita
    Nacci, Vito
    Fiorini, Isabella
    Novellino, Ettore
    Cagnotto, Alfredo
    Mennini, Tiziana
    Sandager-Nielsen, Karin
    Andreasen, Jesper Tobias
    Scheel-Kruger, Jorgen
    Mikkelsen, Jens D.
    Fattorusso, Caterina
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (01) : 151 - 169
  • [27] Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
    Albizu, Laura
    Holloway, Terrell
    Gonzalez-Maeso, Javier
    Sealfon, Stuart C.
    NEUROPHARMACOLOGY, 2011, 61 (04) : 770 - 777
  • [28] Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
    Lukasiewicz, Sylwia
    Polit, Agnieszka
    Kendracka-Krok, Sylwia
    Wedzony, Krzysztof
    Mackowiak, Marzena
    Dziedzicka-Wasylewska, Marta
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12): : 1347 - 1358
  • [29] Effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity
    Betry, C.
    Etievant, A.
    Lambas-Senas, L.
    McCreary, A.
    Haddjeri, N.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S117 - S117
  • [30] 5-HT2 receptors and interactions with 5-HT1A and D2 receptors in the regulation of mesocorticolimbic DA pathways:: In vivo neurochemical evidence
    Ichikawa, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S43 - S43